It is classified as a research chemical, meaning: It cannot be legally marketed as a drug or supplement It is not recognized as "Generally Recognized as Safe" (GRAS) No New Drug Application (NDA) has been submitted It has not undergone the formal FDA approval process Research Chemical Status BPC-157 is available for purchase as a "research chemical" in most jurisdictions, with important caveats: Sold for "research purposes only" Not for human consumption (legally) No quality standards enforced by regulatory agencies Purity and identity depend entirely on supplier integrity International Regulations Regulatory status varies by country: United States : Research chemical, not approved for human use European Union : Not approved, status varies by member state Canada : Not approved for human use, research chemical Australia : Not approved, TGA Category 4 substance United Kingdom : Not approved for human use Sports and Competition BPC-157 is not specifically listed on the World Anti-Doping Agency (WADA) prohibited list, unlike TB-500

Cellular Roles and Conversion Pathways Once injected, cyanocobalamin must convert to methylcobalamin or adenosylcobalamin inside the body
Values above 98 percent suggest high-quality research-grade material
Researchers are studying it for tissue repair, gut protection, and anti-inflammatory effects in preclinical models
Really really good
The nominated uses included chronic insomnia, narcolepsy and opioid withdrawal, with a proposed subcutaneous formulation